記住我
aspartate aminotransferasem
CNScentral nervous system
CTL-4cytotoxic T-lymphocyte antigen-4
EEGelectroencephalography
GGTgamma-glutamyl transferase
ICIsimmune checkpoint inhibitors
irAEsimmune-related adverse events
MRIMagnetic Resonance Imaging
nAEsNeurological immune-related adverse events
NSCLCnon-small-cell lung cancer
PD-1programmed cell death protein 1
PD-L1programmed cell death protein 1 ligand
PRESposterior reversible encephalopathy syndrome
KeywordsTecentriq
anti-PDL1
Adverse drug reaction
Immune checkpoint inhibitor
Central nervous system
Seizures
© 2023 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.
留言 (0)